Wolverine Trading
AVNS icon

Wolverine Trading’s Avanos Medical AVNS Stock Holding History

Wolverine Trading’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,500
Closed -$283K – 4290
2019
Q2 		$283K Buy
+6,500
New +$278K ﹤0.01% 3332
2018
Q4 		– Sell
-3,000
Closed -$206K – 4401
2018
Q3 		$206K Buy
+3,000
New +$193K ﹤0.01% 4230
2017
Q2 		– Sell
-7,800
Closed -$297K – 4244
2017
Q1 		$297K Buy
+7,800
New +$304K ﹤0.01% 3037

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wolverine Trading's AVNS Position: Q2 2019 in Review

Wolverine Trading sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 4,793 shares — an estimated $205K sold.

Wolverine Trading first reported a position in AVNS in Q2 2016 and held it in 3 quarters. The position peaked at $409K in Q4 2016. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Wolverine Trading reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Wolverine Trading sold 4,793 Avanos Medical shares in Q2 2019, an estimated $205K.
  • Wolverine Trading first reported a position in Avanos Medical in Q2 2016 and held it in 3 quarters.
  • Wolverine Trading's Avanos Medical position peaked at $409K in Q4 2016.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.